Editorial: Non-Classic Adrenal Hyperplasia and Autoimmune Disease
DOI:
https://doi.org/10.12970/2310-9874.2015.03.01.1Abstract
Editorial
References
Sacerdote A, Vergara R, Carnegie B. Do All Patients with NIDDM Have Late-Onset Congenital Adrenal Hyperplasia? Program and Abstracts, 76th Annual Meeting of The Endocrine Society 1994; 350: (poster presentation).
Sacerdote A. Adrenal Hyperandrogenemia in NIDDM. Diabetes Care 1995; 18(2): 278-279. http://dx.doi.org/10.2337/diacare.18.2.278b
Sacerdote A. Adrenal Hyperandrogenemia in IDDM. Program and Abstracts, 77th Annual Meeting of The Endocrine Society 1995; 545: (poster presentation).
Sacerdote A. Adrenal Hyperandrogenemia in Graves’ Disease. Program and Abstracts, Tenth International Congress of Endocrinology II 1996; 1000: (poster presentation).
Sacerdote A. Adrenal Hyperandrogenemia in Hashimoto’s Thyroiditis. Program and Abstracts, Tenth International Congress of Endocrinology II: 1996; 1000: (poster presentation).
Sacerdote A, Li Y. Adrenal Hyperandrogenemia in Psoriasis. Program and Abstracts, 79th Annual Meeting of The Endocrine Society 1997; 310: (poster presentation).
Sacerdote A. Vitiligo Is Associated with Adrenal Hyperandrogenemia. Program and Abstracts, 80th Annual Meeting of The Endocrine Society 1998; 199: (poster presentation).
Sacerdote AS, Bahtiyar G, Mejía J. Rheumatoid arthritis is associated with non-classical adrenal hyperplasia. Program and Abstracts, Endo 2007, 89th Annual Meeting of The Endocrine Society 2007; 672: (poster presentation).
Sacerdote A. The expanding universe of androgenic disorders: plasticity of gene expression. Endocrine Today Feb 2005; 4-7.
Bahtiyar G, Sacerdote A. Latest Therapeutic Advances in the Treatment of Congenital Adrenal Hyperplasia in Adolescents and Adults. In “Amenorrhea; publisher-Intech, Amar Chatterjee Ed. ISBN 978-953-307-988-2, 148 pages Published on line 11-2011; published in print 12-2011.
Itariu BK, Stulnig TM. Autoimmune aspects of type 2 diabetes mellitus - a mini-review. Gerontology 2014; 60(3): 189-96. http://dx.doi.org/10.1159/000356747
Speiser PW, Serrat J, New MI, Gertner JM. Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1992; 75(6): 1421-4. http://dx.doi.org/10.1210/jc.75.6.1421
Saygili F, Oge A, Yilmaz C. Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia. Horm Res 2005; 63(6): 270-4. http://dx.doi.org/10.1159/000086363
Atabek ME, Kurtoğlu S, Keskin M. Female pseudohermaphroditism due to classical 21-hydroxylase deficiency and insulin resistance in a girl with Turner syndrome. k J Pediatr 2005; 47(2): 176-9.
Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab 2002; 87(5): 2114-20. http://dx.doi.org/10.1210/jcem.87.5.8456
Kelly SN, McKenna TJ, Young LS. Modulation of steroidogenic enzymes by orphan nuclear transcriptional regulation may control diverse production of cortisol and androgens in the human adrenal. J Endocrinol 2004; 181(2): 355-365. http://dx.doi.org/10.1677/joe.0.1810355
Kalani A, Bahtiyar G, Sacerdote A. Ashwagandha root in the treatment of non-classical adrenal hyperplasia. BMJ Case reports— id: 959152, 2012; 2012.
Kalani A, Thomas N, Sacerdote A, Bahtiyar G. Roux-en-Y gastric bypass in the treatment of non-classic congenital adrenal hyperplasia due to 11-hydroxylase deficiency. BMJ Case Rep 2013 Mar 18; 2013. pii: bcr2012008416. http://dx.doi.org/10.1136/bcr-2012-008416
Mapas-Dimaya AC, Agdere L, Bahtiyar G, Mejia JO, Sacerdote AS. Metformin-responsive classic salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case report. Endocr Pract 2008; 14(7): 889-91. http://dx.doi.org/10.4158/EP.14.7.889
Sacerdote A, Bahtiyar G. Treatment of Congenital Adrenal Hyperplasia by Reducing Insulin Resistance and Cysticercosis Induced Polycystic Ovarian Syndrome. "Contemporary Gynecologic Practice", book edited by Atef Darwish, ISBN 978-953-51-1736-0, Published: February 4, 2015.
Klouda PT, Harris R, Price DA. Linkage and association between HLA and 21-hydroxylase deficiency. J Med Genet 1980; 17(5): 337-341. http://dx.doi.org/10.1136/jmg.17.5.337
Merke DP, Chen W, Morissette R, Xu Z, Ryzin CV, Sachdev V, Hannoush H, Shanbhag SM, Acevedo AT, Nishitani M, Arai AE, McDonnell NB. Tenascin-X Haploinsufficiency Associated with Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2013; 98(2): E379-E387.
Olson NC, Callas PW, Hanley AJG, Festa A, Haffner SM, Wagenknecht LE, Tracy RP. Circulating Levels of TNF-α Are Associated with Impaired Glucose Tolerance, Increased Insulin Resistance, and Ethnicity: The Insulin Resistance Atherosclerosis Study. J Clin Endocrinol Metab 2012; 97(3): 1032-1040. http://dx.doi.org/10.1210/jc.2011-2155
Vitiello M, Bahtiyar G, Sacedote A. Vitamin D Deficiency/Insuficency in Patients with Non-Classic Adrenal Hyperplasia and Response of the Latter to Vitamin D Replacement. Endoc Rev 110: Sun-470; presented at the 94th Annual Meeting of The Endocrine Society 6-24-2012.
Thomas A, Kalani A, Vincent R, Luis-Lam M, Bahtiyar G, Borensztein A, Quinto E, Sacerdote A. Effect of Vitamin D in a patient with classical adrenal hyperplasia due to 11- Hydroxylase deficiency. J Med Cases 2013; 4(8): 569-75. http://dx.doi.org/10.4021/jmc1352w
Dono E, Inoue T, Ezeji G, Baby A, Bahtiyar G, Sacerdote AS. Amelioration of Non-Classic 11-Hydroxylase Deficiency in a Vitamin D Deficient Patient with Weight Loss and Ergocalciferol Program: Abstracts - Orals, Poster Previews, and Posters Session: THR 402-416-Congenital Adrenal Hyperplasia Clinical Thursday, March 5, 2015: 1: 00 PM-3: 00 PM Hall D-F, Adrenal (San Diego Convention Center) Poster Board THR-415.
Sacerdote A, Inoue T, Ezeji G, Baby A, Bahtiyar G. Effect of Ergocalciferol and Simvastatin on a Post-Menopausal Patient with Non-Classic 21-Hydroxylase Deficiency. Program: Abstracts - Orals, Poster Previews, and Posters.
Session: THR 402-416-Congenital Adrenal Hyperplasia Clinical Thursday, March 5, 2015: 1: 00 PM-3: 00 PM Hall D-F, Adrenal (San Diego Convention Center) Poster Board THR-409.
Feldman SR, Matheson R, Bruce S, Grande K, Markowitz O, Kempers S, Brundage T, Wyres M. U0267-301 & 302 Study Investigators. Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials. Am J Clin Dermatol 2012; 13(4): 261-71. http://dx.doi.org/10.2165/11630710-000000000-00000
Sacerdote A. Treatment of Vitiligo with Calcipotriene. Journal of Investigative Medicine 1996; 44(3): 226A, (poster presentation).
Newman MD, Silverberg NB. Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo 2011; 88(5): 256-9.
Arduc A, Dogan BA, Bilmez S, Imga Nasiroglu N, Tuna MM, Isik S, Berker D, Guler S. High prevalence of Hashimoto's thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role? Endocr Res 2015; 1-7. http://dx.doi.org/10.3109/07435800.2015.1015730
